[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

June 2019 - July 1883

Decade

Year

Issue

August 7, 2018, Vol 320, No. 5, Pages 419-516

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2018;320(5):419-421. doi:10.1001/jama.2017.12482
Original Investigation

Effect of a Behavioral Intervention for Underserved Preschool-Age Children on Change in Body Mass Index: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2018;320(5):450-460. doi:10.1001/jama.2018.9128

This randomized clinical trial compares the effects of a 36-month multicomponent behavioral intervention for obesity prevention vs a school-readiness control on body mass index (BMI) trajectories in underserved preschool-age children at risk for obesity but not yet obese.

Effect of a Responsive Parenting Educational Intervention on Childhood Weight Outcomes at 3 Years of Age: The INSIGHT Randomized Clinical Trial

Abstract Full Text
free access has active quiz
JAMA. 2018;320(5):461-468. doi:10.1001/jama.2018.9432

This randomized clinical trial compares the effects of a responsive parenting intervention designed to promote developmentally appropriate, prompt, and contingent responses to an infant’s needs vs a home safety intervention on child weight outcomes at 3 years.

Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non–Small Cell Lung Cancer in the Community Oncology Setting

Abstract Full Text
free access
JAMA. 2018;320(5):469-477. doi:10.1001/jama.2018.9824

This cohort study examines associations between use of broad-based genomic screening vs routine testing (for EGFR and ALK alterations only) to target treatment of advanced non–small cell lung cancer and mortality at 1 year and overall survival.

Research Letter

Opioid Overdose After Surgical Discharge

Abstract Full Text
free access
JAMA. 2018;320(5):502-504. doi:10.1001/jama.2018.6933

This pharmacoepidemiology study uses commercial claims database data to describe the rate of opioid overdose 1 to 3 months after surgical discharge by dose and procedure from 2004 to 2015.

Persistent Opioid Use After Wisdom Tooth Extraction

Abstract Full Text
free access
JAMA. 2018;320(5):504-506. doi:10.1001/jama.2018.9023

This pharmacoepidemiology study uses commercial claims database data to describe the rate of persistent opioid use among patients aged 13 to 30 years prescribed perioperative opioids for wisdom tooth extraction.

US Preventive Services Task Force

Recommendation Statement

Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2018;320(5):478-484. doi:10.1001/jama.2018.10321

This 2018 Recommendation Statement from the US Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for atrial fibrillation (AF) with ECG (I statement).

Evidence Report

Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access
JAMA. 2018;320(5):485-498. doi:10.1001/jama.2018.4190

This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on screening for atrial fibrillation (AF) with electrocardiography (ECG) summarizes published evidence on the benefits and harms of screening and treatment of nonvalvular AF in asymptomatic adults 65 years and older.

Viewpoint

Type 2 Myocardial Infarction—Diagnosis, Prognosis, and Treatment

Abstract Full Text
JAMA. 2018;320(5):433-434. doi:10.1001/jama.2018.7125

This Viewpoint reviews what is known about myocardial infarction (MI) caused by oxygen supply-and-demand mismatch (type 2 MI) and differences from MI caused by coronary artery disease, as well as proposes areas for further investigation to identify optimal management strategies.

Return of Research Results to Study Participants: Uncharted and Untested

Abstract Full Text
JAMA. 2018;320(5):435-436. doi:10.1001/jama.2018.7898

This Viewpoint encourages the development of approaches to share the results of research with study participants to reinforce the value of patient participation, to incentivize engagement in research, and to honor the belief that individuals have a right to their own data.

Progress in Prevention and Treatment of Acute Kidney Injury: Moving Beyond Kidney Attack

Abstract Full Text
JAMA. 2018;320(5):437-438. doi:10.1001/jama.2018.7160

This Viewpoint discusses progress in the recognition and management of acute kidney injury (AKI) since publication in 2012 of KDIGO clinical practice guidelines to improve AKI outcomes, and proposes next steps in management, including use of biomarkers, risk alerts, and care bundles, to improve AKI prevention and outcomes.

Protecting NIH’s Integrity and Trustworthiness in Public-Private Partnerships

Abstract Full Text
JAMA. 2018;320(5):439-440. doi:10.1001/jama.2018.7625

This Viewpoint uses the case of an NIH trial funded by alcohol manufacturers and designed to determine the effects of moderate alcohol consumption on health outcomes to discuss the need for transparency in NIH-private partnerships and ways the NIH can administer those partnerships to preserve its integrity and trustworthiness.

A Piece of My Mind

This Is My Body

Abstract Full Text
JAMA. 2018;320(5):441-442. doi:10.1001/jama.2018.10452

In this narrative medicine essay, a medical student is reminded of Communion service at her New England Protestant church when she sees the beauty of the human anatomy in a cadaver, a former teacher who offered her body as the ultimate teaching moment, in an echo of Jesus’ words at the Last Supper: “This is my body, broken for you. Do this in memory of me.”

Editorial

Preventing Obesity in Children: A Glimmer of Hope

Abstract Full Text
JAMA. 2018;320(5):443-444. doi:10.1001/jama.2018.9442

Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision

Abstract Full Text
JAMA. 2018;320(5):445-446. doi:10.1001/jama.2018.10096

Electrocardiographic Monitoring for Prevention of Atrial Fibrillation–Associated Cardioembolic Stroke

Abstract Full Text
JAMA. 2018;320(5):447-449. doi:10.1001/jama.2018.9185
JAMA Clinical Evidence Synopsis

Probiotics to Prevent Clostridium difficile Infection in Patients Receiving Antibiotics

Abstract Full Text
JAMA. 2018;320(5):499-500. doi:10.1001/jama.2018.9064

This Clinical Evidence Synopsis summarizes a Cochrane review of randomized trials comparing the effects of co-administration of an antibiotic and a probiotic vs placebo or no treatment in adults and children diagnosed with Clostridium difficile infection.

Medical News & Perspectives

At “Crisis Pregnancy Centers,” Critics Say, Ideology Trumps Evidence

Abstract Full Text
JAMA. 2018;320(5):425-427. doi:10.1001/jama.2018.8661

This Medical News story examines the controversy surrounding crisis pregnancy centers.

News From the Food and Drug Administration

Relieving Severe Emphysema Symptoms

Abstract Full Text
JAMA. 2018;320(5):431. doi:10.1001/jama.2018.10737

Another Option for Hyperhidrosis

Abstract Full Text
JAMA. 2018;320(5):431. doi:10.1001/jama.2018.10789

Kratom Investigation Concludes

Abstract Full Text
JAMA. 2018;320(5):431. doi:10.1001/jama.2018.10791
The JAMA Forum

The Health Innovation We Need

Abstract Full Text
free access
JAMA. 2018;320(5):427-429. doi:10.1001/jama.2018.9545
Bench to Bedside

Research Uncovers How Commensal Bacteria Contribute to Multiple Sclerosis

Abstract Full Text
JAMA. 2018;320(5):429-430. doi:10.1001/jama.2017.12863
Poetry and Medicine

Monument

Abstract Full Text
JAMA. 2018;320(5):511. doi:10.1001/jama.2018.2357
JAMA Revisited

Discoveries and Discoverers

Abstract Full Text
JAMA. 2018;320(5):512. doi:10.1001/jama.2017.12501
JAMA Patient Page

Screening for Atrial Fibrillation With Electrocardiography

Abstract Full Text
free access
JAMA. 2018;320(5):516. doi:10.1001/jama.2018.10598

This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening for atrial fibrillation using electrocardiography.

Comment & Response

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain

Abstract Full Text
JAMA. 2018;320(5):506-507. doi:10.1001/jama.2018.6945

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain

Abstract Full Text
JAMA. 2018;320(5):507-508. doi:10.1001/jama.2018.6941

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain

Abstract Full Text
JAMA. 2018;320(5):507. doi:10.1001/jama.2018.6949

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain—Reply

Abstract Full Text
JAMA. 2018;320(5):508-509. doi:10.1001/jama.2018.6953

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain

Abstract Full Text
JAMA. 2018;320(5):508. doi:10.1001/jama.2018.6937

Varicose Veins and Deep Venous Thrombosis

Abstract Full Text
JAMA. 2018;320(5):509-510. doi:10.1001/jama.2018.7319

Varicose Veins and Deep Venous Thrombosis—Reply

Abstract Full Text
JAMA. 2018;320(5):510. doi:10.1001/jama.2018.7331
Correction

Error in Table 1

Abstract Full Text
free access
JAMA. 2018;320(5):510. doi:10.1001/jama.2018.10169

Incorrect Data

Abstract Full Text
free access
JAMA. 2018;320(5):510. doi:10.1001/jama.2018.9890
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2018;320(5):423-424. doi:10.1001/jama.2017.12483
×